How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks Archives

Early Release – Improved Case Detection of Fleaborne Typhus by PCR Testing, Los Angeles County, California, USA, 2022–2024 – Volume 32, Number 9—September 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

August 13, 2026 No Comments

World Hepatitis Day 2026: Despite progress towards eliminating hepatitis in Europe, gaps in prevention measures keep 2030 targets out of reach

Bruno Ciancio of ECDC says: ’No one should die from a disease that is preventable,

August 12, 2026 No Comments

France recommends home isolation for close contacts of hantavirus case, risk ‘low’

French health authorities on Friday recommended home isolation for people who had close contact with

August 12, 2026 No Comments

Early Release – Improved Case Detection of Fleaborne Typhus by PCR Testing, Los Angeles County, California, USA, 2022–2024 – Volume 32, Number 9—September 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

August 12, 2026 No Comments

Early Release – Implementation and Early Outcomes of Laboratory Proficiency Testing Program for National Wastewater Surveillance System, United States, 2024 – Volume 32, Supplement—September 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

August 12, 2026 No Comments

Zika in Indonesia – Level 2 – Level 2 – Practice Enhanced Precautions – Travel Health Notices | Travelers’ Health

Zika is a disease caused by infection with Zika virus and typically occurs in tropical and subtropical

August 11, 2026 No Comments

Rare cruise ship virus outbreak highlights public messaging lessons and disease preparedness

A small outbreak of a rare hantavirus on a cruise ship earlier this year captured

August 10, 2026 No Comments

Early Release – Implications of Wastewater Surveillance for Clinical Care among Infectious Disease Physicians, United States, 2024 – Volume 32, Supplement—September 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

August 10, 2026 No Comments

Early Release – Exploration of Public Perceptions of Wastewater Surveillance, United States, June 2024 – Volume 32, Supplement—September 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

August 9, 2026 No Comments

Health officials say new hantavirus patient in Spain may have been contagious for 10 days

Alyssa Mcmurtry 07 August 2026•Update: 07 August 2026 A Franco-Argentine tourist isolated in Spain after

August 9, 2026 No Comments

Early Release – Improved Case Detection of Fleaborne Typhus by PCR Testing, Los Angeles County, California, USA, 2022–2024 – Volume 32, Number 9—September 2026 – Emerging Infectious Diseases journal

World Hepatitis Day 2026: Despite progress towards eliminating hepatitis in Europe, gaps in prevention measures keep 2030 targets out of reach

France recommends home isolation for close contacts of hantavirus case, risk ‘low’

Early Release – Improved Case Detection of Fleaborne Typhus by PCR Testing, Los Angeles County, California, USA, 2022–2024 – Volume 32, Number 9—September 2026 – Emerging Infectious Diseases journal

Early Release – Implementation and Early Outcomes of Laboratory Proficiency Testing Program for National Wastewater Surveillance System, United States, 2024 – Volume 32, Supplement—September 2026 – Emerging Infectious Diseases journal

Zika in Indonesia – Level 2 – Level 2 – Practice Enhanced Precautions – Travel Health Notices | Travelers’ Health

Rare cruise ship virus outbreak highlights public messaging lessons and disease preparedness

Early Release – Implications of Wastewater Surveillance for Clinical Care among Infectious Disease Physicians, United States, 2024 – Volume 32, Supplement—September 2026 – Emerging Infectious Diseases journal

Early Release – Exploration of Public Perceptions of Wastewater Surveillance, United States, June 2024 – Volume 32, Supplement—September 2026 – Emerging Infectious Diseases journal

Health officials say new hantavirus patient in Spain may have been contagious for 10 days

Schedule an Appointment

Quick Links

Patient Forms

Contact Us